Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Ned Tijdschr Geneeskd ; 1662022 03 21.
Artículo en Holandés | MEDLINE | ID: mdl-35499542

RESUMEN

BACKGROUND: Nail psoriasis, also called psoriasis unguium, is a variant of psoriasis in which nail changes appear due to inflammation of nail bed or nail matrix. 15% to 50% of patients with cutaneous psoriasis have nail psoriasis, the condition also occurs without or before the appearance of skin lesions. CASE DESCRIPTION: A 54-year-old male visits his general practitioner because of crumbling of his fingernails. Upon clinical examination, this was interpreted as onychomycosis and treated with oral antimycotics. Due to the lack of improvement and a negative PCR-test on dermatophytes, the condition was later diagnosed as nail psoriasis. CONCLUSION: Nail psoriasis is often diagnosed as fungal infection of the nails. To make the right diagnosis, a complete medical history should be obtained, and physical examination of skin and joints need to be conducted. Furthermore, we advise to rule out onychomycosis in patients with known skin psoriasis to prevent overtreatment with antimycotics.


Asunto(s)
Enfermedades de la Uña , Onicomicosis , Psoriasis , Humanos , Masculino , Persona de Mediana Edad , Enfermedades de la Uña/diagnóstico , Uñas/patología , Onicomicosis/complicaciones , Onicomicosis/diagnóstico , Onicomicosis/microbiología , Psoriasis/diagnóstico , Piel/patología
2.
Acta Psychiatr Scand ; 104(4): 311-3; discussion 313-4, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11722307

RESUMEN

OBJECTIVE: Quetiapine is a recently introduced atypical antipsychotic. Although adverse effects are mainly mild, more serious infrequent adverse effects including leucopenia are mentioned. METHOD: We describe three case-reports concerning haematological adverse effects of quetiapine. RESULTS: Quetiapine was associated with leucopenia in two patients and clinically apparent agranulocytosis in one patient. CONCLUSION: Although a definite association has not been proven, clinicians should be aware of the possibility of agranulocytosis while using quetiapine. Further post-marketing surveys are required.


Asunto(s)
Agranulocitosis/inducido químicamente , Antipsicóticos/efectos adversos , Dibenzotiazepinas/efectos adversos , Esquizofrenia Paranoide/tratamiento farmacológico , Adulto , Agranulocitosis/diagnóstico , Antipsicóticos/uso terapéutico , Dibenzotiazepinas/uso terapéutico , Relación Dosis-Respuesta a Droga , Humanos , Masculino , Persona de Mediana Edad , Escalas de Valoración Psiquiátrica , Fumarato de Quetiapina , Esquizofrenia Paranoide/diagnóstico , Esquizofrenia Paranoide/psicología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...